The Entire Biomarker Value Chain in One Company
Building on our extensive expertise and cutting-edge technology
ions.bio offers a comprehensive, all-in-one solution for biomarker development. We design biomarker studies, collect biosamples with our clinical experts, and convert these samples into extensive multi-omics datasets. These datasets are rigorously analyzed using our proprietary data processing, bioinformatics, and AI-driven software suite. The outcome is a new generation of innovative biomarkers.
We actively collaborate with biotech and pharma companies, providing end-to-end support and services around biomarker research to accelerate drug and diagnostics development programs.
Biomarker Discovery and Validation
ions.bio utilizes advanced mass spectrometry-based proteomics, lipidomics, and metabolomics to discover and validate novel biomarkers. Our innovative approach enables us to provide critical insights that can transform disease diagnosis and drug development. By bridging our sample collection with cutting-edge technology, we are committed to advancing personalized medicine and improving health outcomes.
Clinical Trial Patient Stratification
We empower pharmaceutical partners by providing crucial support for clinical trials through advanced biomarker discovery and validation. We specialize in developing and delivering high-quality predictive biomarkers, enabling precise patient stratification and enhancing the overall effectiveness of clinical studies. By leveraging our expertise, we help streamline the drug development process, potentially reducing costs and accelerating time-to-market for new therapeutics.
Pharmacodynamic Biomarker Services
We help identify and establish pharmacodynamic biomarkers through our advanced mass spectrometry platform and our sensitive AI-driven data analysis pipeline. Our in-house database, built from years of experience, aids in validating and selecting the best markers. Partnering with ions.bio accelerates the drug discovery process, enabling informed preclinical and clinical research decisions.
Customer-Centric Approach
We are committed to providing a full customer experience service, ensuring our clients receive dedicated support and guidance throughout their engagement with our biomarker discovery and validation services.